Trials / Conditions / Tick-borne Encephalitis (TBE)
Tick-borne Encephalitis (TBE)
4 registered clinical trials studyying Tick-borne Encephalitis (TBE) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910 | Institut Pasteur du Cambodge | — |
| Recruiting | Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic NCT07274046 | Charles University, Czech Republic | — |
| Completed | TBE Seropersistence up to 10 Years After First Booster in Adults NCT01582698 | Pfizer | Phase 4 |
| Completed | An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses A NCT01106482 | Novartis Vaccines | Phase 4 |